ConductScience.org, home

Trial · NCT06395194

Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

NCT06395194, Phase 3, Completed, Oslo University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension. Trials, record NCT06395194. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06395194

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
NCT number
NCT06395194
Status
Completed
Phases
Phase 3
Enrollment
15,313 participants, actual
Lead sponsor
Oslo University Hospital
Conditions
Essential Hypertension
Interventions
Cardiac outcomes on treatment with valsartan, Cardiac outcomes on treatment with amlodipine
First posted
2024-05-02
Last updated
2024-05-02

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryComposite cardiac event (mostly myocardial infarction and heart failure hospitalization)Up to 6 years
Composite cardiac events, which included a combination of fatal or non-fatal myocardial infarction, sudden cardiac death, death from revascularization procedures or heart failure, hospitalization for heart failure, and emergency procedures to prevent myocardial infarction
SecondaryEnd-stage kidney failureUp to 6 yearsIncident end-stage kidney disease being patients in need for dialysis or kidney transplantation
SecondaryWorsened kidney functionUp to 6 yearsNo of patients with at least 50% increase of serum creatinine.
SecondaryAll cardiovascular eventsUp to 6 yearsAll cardiovascular events
SecondaryStrokeUp to 6 yearsFatal and non-fatal stroke
SecondaryMyocardial infarctionUp to 6 yearsFatal and non-fatal myocardial infarction
SecondaryHeart failureUp to 6 yearsHospitalized for heart failure
SecondaryCardiovascular mortalityUp to 6 yearsAll deaths from cardiovascular disease
SecondaryNon-cardiovascular mortalityUp to 6 yearsAll deaths from causes other than cardiovascular disease
SecondaryAll-cause mortalityUp to 6 yearsAll deaths during folllow-up, from all causes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
15207952RESULTPubMed
40397037DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06395194

GET https://conductscience.org/api/trials/v1/NCT06395194/registered